The evaluation of lymphopenia in infants exposed to opioids in-utero
J Neonatal Perinatal Med
© 2020-IOS Press and the authors. All rights reserved. BACKGROUND: Chronic use of opioids is associated with hematologic and immunologic effects, including lymphopenia. Despite an increase in opioid use during pregnancy, little is known about the potential immunologic effects on the neonate after exposure to opioids in-utero. We aimed to evaluate the presence of lymphopenia among neonates exposed to opioids in-utero. METHODS: We conducted a retrospective chart review of infants admitted to the neonatal intensive care unit (NICU) of a single institution after exposure to opioids in-utero. We compared the lymphocyte counts of this population to a control NICU population. RESULTS: A higher percentage of neonates exposed to opioids in-utero were lymphopenic compared to our control population (44% vs 24%, p = 0.035). CONCLUSIONS: This is the first study we are aware of, that investigated an association between neonatal lymphopenia and opioid exposure in-utero. Further studies to explore clinical implications of this finding are needed.
87 - 90
Faculty; Northwell Researcher; Northwell Resident
School of Medicine; Northwell Health
This document is currently not available here.
Hofstra Northwell School of Medicine and Northwell Health currently do not subscribe to this title. If you are an affiliate and would like to access the full text please request it via interlibrary loan via Hofstra Northwell School of Medicine ILL (faculty and students only) or Northwell Health ILL